Tumors

Related by string. tumor * * malignant brain tumor . cancerous brain tumor . battling brain tumor . brain tumor . cancerous tumor removed . remove cancerous tumor . remove malignant tumor . brain tumors . remove benign tumor . noncancerous tumor pressing . frequently benign tumor . solid tumors . lung tumors . lymphoid tumors currently . cancerous tumor . benign brain tumor *

Related by context. All words. (Click for frequent words.) 73 Tumours 73 tumors 69 Polyps 66 Cancers 66 melanoma tumors 65 Lesions 65 Metastases 64 Cancer Cells 64 Gliomas 63 lung tumors 63 Carcinoma 63 Breast Cancers 63 Metastatic 62 Melanomas 62 pancreatic tumors 62 GBM tumors 62 tumor 62 Sarcomas 61 metastases 61 Meningiomas 61 Breast Tumors 61 Tumor Cells 61 Cysts 61 anaplastic 61 breast tumors 60 prostate tumors 60 Breast Cancer Cells 60 Blood Vessels 60 Malignant 60 GISTs 60 cancerous tumors 60 Carcinomas 60 ovarian tumors 59 Tumor Growth 59 metastatic lesions 59 Fibroblasts 59 Lymphomas 59 seminomas 59 Leukemias 59 neuroblastoma tumors 59 Brain Tumors 59 glioblastomas 59 Nodules 59 B Cell Lymphoma 58 Skin Cancers 58 Adenocarcinoma 58 glioblastoma tumors 58 prostate tumor 58 Aneurysms 58 Papillary 58 Glioma 58 Malignant Melanoma 58 Gene Mutation 58 Prostate Cancers 58 Squamous Cell Carcinoma 58 leiomyomas 58 metastatic tumors 58 tumor cells 58 bladder cancers 58 malignant cells 58 Cancerous 58 pulmonary metastases 57 Progenitor Cells 57 Fibroids 57 paragangliomas 57 Cancer Stem Cells 57 diverticula 57 Immune Responses 57 Pancreatic 57 meningiomas 57 Gene Mutations 57 prostate cancers 57 neuroblastomas 57 Anthracycline 57 Lung Cancer Patients 57 adenocarcinomas 57 carcinoid tumors 57 Metastasis 57 Small Intestine 57 cisplatin resistant 57 Malignancies 57 papillary 57 Lung Tumors 57 schwannomas 56 Colon Polyps 56 Tumor 56 Mesenchymal Stem Cells 56 Tumor cells 56 Neoplasms 56 lipomas 56 Cells 56 seminoma 56 lesions 56 Thyroid Cancer 56 Biopsies 56 mucinous 56 Breast Cancer Patients 56 malignant tumors 56 pre cancerous growths 56 Endometrial 56 hyperplastic 56 Premature Aging 56 cancerous cells 56 ductal 56 Cytotoxic T 56 Precancerous 56 neuroendocrine tumors 56 adenomas 56 micrometastases 56 Tumor Cell 56 Antitumor Activity 56 Aggressive Prostate Cancer 56 pancreatic tumor 56 Renal Cell Carcinoma 56 lung adenocarcinomas 56 vestibular schwannomas 56 Potent Anti 56 Blood Vessel 56 Signaling Pathways 56 osteosarcomas 56 Insulin Resistance 56 pituitary adenomas 55 Endothelial Cells 55 Ovarian Cancer Patients 55 Fibroblast 55 Asymptomatic 55 Mouse Model 55 Breast Cancer Metastasis 55 squamous cell carcinoma SCC 55 urothelial carcinoma 55 Metastatic Cancer 55 mesothelial cells 55 Nerve Cells 55 Allogeneic 55 Cancer Treatments 55 grade gliomas 55 endometrial cancers 55 Immune Cells 55 Mouse Models 55 lymph nodes 55 Transcription Factor 55 Stomach Cancer 55 Myelodysplastic Syndromes 55 glioblastoma cells 55 colon tumors 55 epithelial tumors 55 carcinoma 55 Fat Cells 55 Cancerous cells 55 Chemotherapy 55 uterine tumors 55 Epithelial Cells 55 basal cell carcinomas 55 Nanoparticles 55 lymphomas 55 leukemic cells 55 malignant prostate 55 Prostate Biopsy 55 Mesenchymal 55 Dendritic Cells 55 Peripheral Blood 55 Glioblastoma 55 basal cell cancers 55 Cell Lymphoma 55 Basal Cell 55 malignant cancerous 55 Hemangiomas 55 Drug Resistant 55 Bacterial Infections 54 breast cancers 54 Recurrences 54 Tumor Suppressor Gene 54 colorectal carcinomas 54 Carcinoid tumors 54 noncancerous cells 54 breast carcinoma 54 lymph node metastases 54 neuroblastoma cells 54 Esophageal Cancer 54 adenocarcinoma 54 cancers 54 Acoustic neuromas 54 neurofibromas 54 Breast Cancer Recurrence 54 Prostatic 54 mammary tumors 54 Cell Proliferation 54 pleomorphic 54 neoplastic cells 54 cancerous growths 54 PCa 54 colorectal neoplasms 54 lobules 54 atypical hyperplasia 54 Anaplastic 54 Choroidal 54 Differentially 54 Adenoma 54 Neurons 54 breast carcinomas 54 cysts 54 Prostate Tumors 54 squamous cells 54 Neural Stem Cells 54 Bortezomib 54 Hyperplasia 54 p# mutations 54 Liver Cells 54 Genetic Variations 54 Bladder Cancer 54 Epidermal Growth Factor Receptor 54 thyroid nodules 54 prostate adenocarcinoma 54 cystic lesions 54 Disease Progression 54 PNET 54 basal cells 54 Reprogrammed 54 Non Alcoholic Fatty 54 Rectal Cancer 54 hemangiomas 54 Liver Tumors 54 esophageal tumors 54 Gleevec resistant 54 Ovarian Cancers 54 squamous cell carcinomas 54 GIST tumors 54 Esophageal 54 Estrogens 54 Malignant tumors 54 basal cell skin 54 Basal cell 54 astrocytoma 54 Cell Transplants 54 pituitary tumors 54 breast epithelial cells 54 BRAF V#E 54 Antigens 54 polypoid 54 Adjuvant Chemotherapy 54 midgut 54 Abscesses 54 Colorectal Adenomas 54 Renal Cell Cancer 54 benign growths 54 subependymal giant cell 54 cell carcinomas 54 Lymph Nodes 53 Mutational 53 Adenomas 53 lymphatic vessels 53 Breast Tissue 53 Glioblastomas 53 Lymph Node 53 adenoma 53 Autoantibodies 53 Basal Cell Carcinoma 53 explants 53 Tumor Suppressor 53 cell carcinoma 53 Malignant Glioma 53 lung nodules 53 Iron Deficiency 53 Unresectable 53 pancreatic cancers 53 Proves Effective 53 metastatic melanomas 53 B7 H3 53 glioma cells 53 Metastatic Disease 53 Brain Cells 53 Chronic Lymphocytic Leukemia CLL 53 Lymphoid 53 Toxicities 53 Genes Linked 53 Metastatic Prostate Cancer 53 hormone secreting 53 Hematopoietic 53 papillomas 53 xenograft tumors 53 lymphatics 53 EGFRvIII 53 medulloblastoma 53 lymphatic tissue 53 fibroadenomas 53 malignant growths 53 Drug Resistant Bacteria 53 Predict Breast Cancer 53 BRAF gene 53 Fluorouracil 53 gliomas 53 Colon Cancers 53 motile cells 53 Epithelial 53 myoblasts 53 benign polyps 53 myocytes 53 endostatin 53 mammary cancers 53 Skeletal Muscle 53 metastatic neuroendocrine tumors 53 Colorectal Cancers 53 desmoplastic 53 castrate resistant 53 Abnormalities 53 hepatoma 53 Radiofrequency Ablation RFA 53 Anti Tumor Activity 53 atherosclerotic lesions 53 Genetic Variant 53 Signaling Pathway 53 Inhibits 53 Bacterial Infection 53 microvessels 53 Peritoneal 53 renal carcinoma 53 colorectal carcinoma 53 Embryonic Stem Cells 53 teratomas 53 Intracranial 53 Postmenopausal Women 53 prostate tissue 53 Liver Injury 53 Lung Cancers 53 Liver Metastases 53 IGF1R 53 premalignant 53 Knee Osteoarthritis 53 Immunosuppression 53 benign tumors 53 melanocytic nevi 53 lymphoid tissue 53 lymphoid cells 53 Diverticulosis 53 EGF receptors 53 Lung Cancer Survival 53 RNA Interference 53 Follicular 53 Hernias 53 Squamous cell carcinomas 53 carcinomas 53 Invasive Breast Cancer 53 amyloid deposits 53 prostate carcinomas 53 PIK3CA 53 Grafts 53 Blood Clots 53 mononuclear cells 53 Magnetic Nanoparticles 53 pancreatic adenocarcinoma 53 colorectal tumors 53 ductal breast cancer 53 Cisplatin 52 myeloma cells 52 Lymphocytes 52 Pancreas Cancer 52 colorectal gastric 52 Skin Cells 52 Glucocorticoids 52 Genetic Mutation 52 Endothelial 52 SPINK1 52 Circulating Tumor Cells 52 Myocardial Ischemia 52 Gastric Cancer 52 Gene Variant 52 Kidney Stones 52 Gallbladder 52 Neutrophils 52 Acute Myelogenous Leukemia 52 Survival Benefit 52 paraganglioma 52 Alveolar 52 Decitabine 52 ovarian cancers 52 cervical lymph nodes 52 Short Stature 52 multinucleated giant cells 52 Breast Cancer Risk 52 Glucocorticoid 52 Researchers Identify 52 Estrogen Receptor 52 C EBP alpha 52 Lumpectomy 52 highly vascularized 52 polyps growths 52 Gene Linked 52 bronchogenic carcinoma 52 Insulin Sensitivity 52 renal cell carcinomas 52 Glioblastoma Multiforme 52 atherosclerotic plaques 52 Genetic Variation 52 Organ Rejection 52 neoadjuvant therapy 52 Chronic Myeloid Leukemia 52 basal cell 52 hamartomas 52 Resection 52 advanced adenomas 52 indolent tumors 52 Coronary Artery 52 IFNg 52 Androgen 52 ADPKD 52 colorectal liver metastases 52 Brain Aneurysms 52 mammary cells 52 lymph vessels 52 acinar cells 52 Antibodies 52 Nanoparticle 52 aneuploid cells 52 Advanced Melanoma 52 immunocompetent 52 Anti Tumor 52 Targeted Therapies 52 Uterine fibroids 52 cyclin E 52 precursor lesions 52 Hematologic 52 Ovarian Tissue 52 Certain Cancers 52 Chronic Pelvic Pain 52 proto oncogene 52 malignant lymphoma 52 Brain Atrophy 52 glandular tissue 52 gastrointestinal stromal tumors GIST 52 Prolongs Survival 52 metastatic tumor 52 tumoral 52 Relapsed Refractory 52 metastasis 52 Oncolytic Reovirus 52 Cancer Recurrence 52 histologically 52 Immunohistochemical analysis 52 Prolonged Survival 52 Chemotherapeutic Agents 52 squamous cell cancers 52 CD# + [001] 52 Vorinostat 52 Scientists Identify 52 Inflammatory Markers 52 alveolar epithelial cells 52 Thymic 52 Intracellular 52 Adiposity 52 Lymphatic 52 pancreas 52 Transcriptome 52 MALT lymphoma 52 metastatic prostate cancer 52 Chromosomes 52 Preclinical Models 52 astrocytomas 52 Autologous 52 glioma tumors 52 leiomyoma 52 Prostate Cancer Patients 52 Chronic Inflammation 52 medulloblastomas 52 Intestine 52 HER2 positive tumors 52 Bowel Disease 52 Clots 52 Childhood Leukemia 52 Abdominal Fat 52 plexiform neurofibromas 52 Synthase 51 lobular carcinoma 51 sentinel nodes 51 Intestinal 51 Hypertrophy 51 Soft Tissue Sarcoma 51 fibromatosis 51 intraductal 51 mesangial 51 Viral Infection 51 Macrophage 51 Squamous 51 Cardiac Function 51 myelomas 51 prostate carcinoma 51 Lymph nodes 51 Embolization 51 Lung Cancer Risk 51 trophoblasts 51 Cholangiocarcinoma 51 PTEN gene 51 Immune Cell 51 Lesion 51 soft tissue sarcomas 51 JAK2 enzyme 51 Metastatic Colorectal Cancer 51 androgen receptors 51 vimentin 51 Mammalian 51 leukoplakia 51 Psoriatic 51 metastatic disease 51 Kidney Failure 51 Hurthle cell 51 milk ducts 51 Apoptosis 51 apocrine 51 Neuroendocrine tumors 51 Prostate Cancer Surgery 51 Induces 51 MGUS 51 Tyrosine Kinase 51 Progenitor Cell 51 cancerous lesions 51 Increased Risk 51 Squamous cell 51 teratoma 51 Cell Lung Cancer 51 distant metastases 51 metastasise 51 lung metastases 51 thymoma 51 NKT cells 51 Leukemia Cells 51 iNOS 51 goblet cells 51 Xenografts 51 Kinase Inhibitors 51 Factor Receptor 51 NKX2 51 IGFBP 51 lymph glands 51 Chronic Lymphocytic Leukemia 51 Cognitive Decline 51 Lung Transplants 51 Chronic Myelogenous Leukemia 51 androgen receptor AR 51 Pathogens 51 keloid 51 uPAR 51 Viruses 51 Transgenic Mice 51 carcinoid 51 epithelial tissues 51 primary cilia 51 perivascular 51 lobular carcinomas 51 Pancreatic NET 51 Herpes Virus 51 Monocytes 51 Testes 51 Germline 51 oligodendroglioma 51 KIT mutations 51 transfected cells 51 ACE Inhibitors 51 fibroids 51 Cocaine Addiction 51 epithelial ovarian 51 TGF beta signaling 51 polyps 51 prostate bladder 51 dysplastic 51 Ischemic 51 Bone Marrow Cells 51 Breast Cancer Treatment 51 Autoimmune Disorders 51 calculi 51 Coronary Arteries 51 Cytotoxicity 51 liposarcoma 51 Solid Tumors 51 thyroglobulin 51 Duodenal 51 neoplasms 51 Genes Associated 51 Histologically 51 intestinal polyps 51 NSCLC tumors 51 lymph node involvement 51 TET2 51 Protein Kinase 51 Ovarian Cancer Risk 51 Skin Lesions 51 Diabetic Patients 51 Gene Variants 51 Genetic Mutations 51 HbF 51 overexpress 51 nodular melanoma 51 Bacteria 51 Advanced Colorectal Cancer 51 Calcium Supplements 51 cervical lesions 51 lymphadenopathy 51 papillary renal cell carcinoma 51 Breast Cancer Stem Cells 51 renal tumors 51 mesenchymal cells 51 lung carcinomas 51 Pancreatic Cancer 51 Epstein Barr Virus 51 precancerous polyp 51 Prostate Cancer Cells 51 Compounds 51 MDSCs 51 HER2 Positive Breast Cancer 51 Stem Cell Transplant 51 cancerous polyps 51 cells hESCs 51 Slow Progression 51 Caveolin 1 51 testis 51 IDH1 mutations 51 Findings Suggest 51 Osteoporosis Drugs 51 Hepatocellular Carcinoma 51 choriocarcinoma 51 Genes Predict 51 Fludarabine 51 Patients Treated 51 adenomatous polyps 51 microfilariae 51 Patients Treated With 51 lymph node 51 axillary lymph nodes 51 DCIS 51 Benign tumors 51 Prostate Cancer Risk 51 Drug Prevents 51 NF kB pathway 51 KRAS oncogene 51 Hepatocellular Carcinoma HCC 51 Angiogenesis 51 microglial cells 51 Prostate Cancer Treatment 51 Polymorphisms 51 angiosarcoma 51 Fibrosis 51 Tumor Necrosis Factor 51 Cell Adhesion 51 inoperable tumors 51 CLL cells 51 ascites 51 Hypothyroidism 51 mesothelin 51 Improves Outcomes 51 Antibody 51 Epitopes 51 malignancies 51 apical membrane 51 A. fumigatus 51 Emboli 51 WT1 51 Calcification 51 Disease Causing 51 primitive neuroectodermal tumors 51 Hepatocellular 51 Recurrence 51 Drug Combo 50 TAp# 50 Oxidative Stress 50 neoplasias 50 Improve Survival 50 stroma 50 fibroblast cells 50 Thrombocytopenia 50 Astrocytoma 50 Epoetin Alfa 50 Nonalcoholic Fatty Liver Disease 50 Neuronal 50 melanomas 50 Naive Patients 50 Previously Treated 50 Critically Ill Patients 50 parotid 50 Doxorubicin 50 myxoid 50 chemo resistant 50 Treatable 50 EGFr 50 Pituitary 50 brain tumors 50 liver metastases 50 Synovial 50 malignant nodules 50 Angiogenic 50 Ovarian 50 Testicular 50 IGFBP 3 50 intestinal metaplasia 50 Commonly Used 50 nutlin 3a 50 Genes Identified 50 peritoneal carcinomatosis 50 lipoma 50 keloids 50 sarcomatoid 50 Acellular 50 mutated BRAF gene 50 mesenteric 50 Stem Cell Transplants 50 EGFR protein 50 Cholesterol Levels 50 Beta Blockers 50 Phosphorylation 50 endocrine tumors 50 Complication Rates 50 synovium 50 Dasatinib 50 Androgen Deprivation Therapy 50 Oral Cavity 50 Xenograft 50 pleura 50 liver metastasis 50 Enlarged Prostate 50 TGF β 50 Oncogenes 50 Chimeric 50 Effective Treatments 50 Appears Safe 50 Improved Survival 50 imatinib Gleevec 50 differentiated thyroid 50 MEFs 50 Dysplasia 50 underarm lymph nodes 50 endometrial tumors 50 tumor nodules 50 Abnormality 50 Epileptic Seizures 50 Quantum Dots 50 abnormal growths 50 Imatinib 50 gastrointestinal stromal tumors 50 Corticosteroids 50 adenomatous 50 haematopoietic 50 breast endometrial 50 thrombi 50 basal cell cancer 50 carcinoid tumor 50 hematopoietic cells 50 Artery Disease 50 urothelium 50 malignancy 50 Lung Cancer Deaths 50 Inactivation 50 Antibiotic Resistant 50 Patients Undergoing 50 Urinary Incontinence 50 Mastectomy 50 Atypical Hemolytic Uremic Syndrome 50 fibrin deposition 50 granulomas 50 tumor regrowth 50 desmoid tumor 50 IGF 1R 50 Tumour 50 Intracerebral Hemorrhage 50 Blood Transfusions 50 invasive carcinoma 50 ependymomas 50 Human Papilloma 50 Multidrug Resistant 50 cutaneous melanoma 50 Pediatric Patients 50 esophagogastric junction 50 vulvar intraepithelial neoplasia 50 Inflammatory Diseases 50 Antibiotic Resistance 50 Radiation Dose 50 Colorectal Cancer Patients 50 PC3 cells 50 HER2 receptors 50 glioblastoma 50 P. gingivalis 50 Larvae 50 Kidney Tumors 50 noncalcified 50 Brain metastases 50 Kidneys 50 somatostatin receptors 50 Preterm Delivery 50 mutated KRAS gene 50 neoplasm 50 lobular 50 Genetic Disorder 50 epithelioid 50 pDC 50 Cystectomy 50 urothelial 50 Heart Failure Patients 50 Follicular Lymphoma 50 neoplastic 50 Wwox 50 cells cardiomyocytes 50 ovarian carcinoma 50 squamous cell cancer 50 Reflux Disease 50 Protein Linked 50 Therapeutic Efficacy 50 Skin Infection 50 eccrine 50 anal canal 50 IDH1 mutation 50 prostate epithelial cells 50 Premenopausal Women 50 progenitor cells 50 Breast Cancer Tumors 50 basal cell carcinoma BCC 50 primitive neuroectodermal tumor 50 CB2 receptors 50 malignant tissues 50 Viral Infections 50 chromosome aberrations 50 Bacterium 50 adrenocortical carcinoma 50 pancreatic islet 50 synovial sarcoma 50 Adhesions 50 Implantation 50 extrahepatic 50 Lupus Nephritis 50 NKX#.# 50 MicroRNAs 50 Tyrosine Kinase Inhibitor 50 Squamous Cell 50 HGPIN 50 Castration Resistant Prostate Cancer 50 Fungal Infection 50 leukoencephalopathy 50 estrogen receptor negative 50 Liposomes 50 Rheumatoid Arthritis Patients 50 Patients Receiving 50 pheochromocytomas 50 Laryngeal 50 TP# mutation 50 bowel cancers 50 M1 macrophages 50 spontaneously regress 50 Beneficial Effects 50 Metastatic Renal Cell Carcinoma 50 cytologically 50 Genotypes 50 gastric cancers 50 Cancer Therapies 50 beta islet cells 50 Liver Cancer 50 Tubulin 50 Genetic Variants 50 Radical Prostatectomy 50 Randomized Study 50 colorectal adenocarcinoma 50 CDK4 50 multinucleated 50 Excision 50 survivin 50 Mammalian Cells 50 X Chromosome 50 meningeal 50 cytologically confirmed 50 pT2 50 Unfractionated Heparin 50 Detect Cancer 50 Septic Shock 50 Myopathy 50 Smooth Muscle 50 coronary vessels 50 oncoproteins 50 testicular cancers 50 Breast Cancer Treatments 50 TNF Alpha 50 biopsy specimen 50 invadopodia 50 endometrial 49 Proliferative 49 p# deficient 49 IGF IR 49 grade glioma 49 Cardiovascular Events 49 Oncogenic 49 Fracture Risk 49 MMP2 49 noncancerous tumors 49 osteoid 49 Bone marrow stem cells 49 colon cancers 49 Therapeutic Effects 49 Reovirus 49 Hepatocytes 49 gastric adenocarcinoma 49 parenchyma 49 endometrial tissue 49 Dialysis Patients 49 Cause Mortality 49 nonmelanoma skin cancers 49 HER2 amplification 49 Adult Stem Cells 49 Basal cell carcinomas 49 Nerve Cell 49 stem progenitor cells 49 Drug Resistant TB 49 Rap1 49 kidney cysts 49 Infectivity 49 diseased tissues 49 Neural stem cells 49 Keloids 49 endometrium 49 PDGF receptor 49 Anticancer Drugs 49 Tyrosine Kinase Inhibitors 49 pre cancerous polyps 49 leukaemias 49 Gum Disease 49 Biopsy 49 Acute Pancreatitis 49 transitional cell carcinoma 49 Novel Method 49 Smad7 49 solid tumors 49 Cancer Patients Treated 49 cardiac fibroblasts 49 epithelia 49 Prostatectomy 49 Breast Biopsies 49 Suppresses 49 Hepatocyte 49 thymic carcinoma 49 Phosphatase 49 calcified plaques 49 Survival Rates 49 Pre Cancerous 49 biliary tract cancer 49 enlarged spleens 49 LDLR 49 gastrointestinal stromal tumor GIST 49 CCN2 49 parasite Leishmania 49 adhesion molecule 49 neoplastic lesions 49 Vaccine Shows Promise 49 Binding Protein 49 lymphoid organs 49 lymphoid 49 chitinase 49 Resistant Bacteria 49 hypoperfusion 49 pannus 49 Clogged Arteries 49 Bevacizumab 49 OGG1 49 Lymphocyte 49 Antitumor 49 Transcriptional 49 molecular abnormalities 49 bursae 49 Improves Survival 49 radiofrequency ablation RFA 49 p#NTR 49 Premature Infants 49 metastatic prostate 49 transthyretin 49 Monoclonal Antibodies 49 Cytotoxic 49 hypermethylation 49 myofibroblasts 49 ocular melanoma 49 Peanut Allergies 49 Oral Fingolimod 49 Comorbidities 49 myeloid cells 49 Ulcerative Colitis 49 precancerous tissue 49 neuroblastoma tumor 49 Surgical Procedures 49 Endometrial Cancer 49 carcinoid cancer 49 epithelial cells 49 lymphocytic 49 lung metastasis 49 precancerous lesion 49 Cancerous tumors 49 Aspirin Reduces 49 Newly Diagnosed 49 removed laparoscopically 49 Hyperlipidemia 49 metastatic gastric 49 Ulcers 49 oesophageal adenocarcinoma 49 adrenal cortex 49 Systemic Delivery 49 Prognostic Factors 49 pituitary adenoma 49 lymphangiogenesis 49 inflamed tissues 49 cystectomy

Back to home page